Axsome Therapeutics (AXSM) Inventory (2022 - 2026)

Axsome Therapeutics (AXSM) has 5 years of Inventory data on file, last reported at $31.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 93.12% year-over-year to $31.5 million; the trailing twelve-month figure through Mar 2026 stood at $31.5 million (up 93.12% YoY), and the FY2025 full-year result was $27.9 million, up 77.59% from the prior year.
• Inventory climbed to $31.5 million in Q1 2026, from $27.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $31.5 million in Q1 2026 to a low of $4.3 million in Q4 2022.
• A 5-year average of $16.3 million and a median of $15.2 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 250.35% in 2023 and sank 38.6% in 2025, its largest moves.
• Tracing AXSM's Inventory over 5 years: stood at $4.3 million in 2022, then soared by 250.35% to $15.1 million in 2023, then climbed by 3.94% to $15.7 million in 2024, then surged by 77.59% to $27.9 million in 2025, then gained by 12.8% to $31.5 million in 2026.
• Business Quant data shows AXSM's Inventory at $31.5 million in Q1 2026, $27.9 million in Q4 2025, and $23.8 million in Q3 2025.